Andhra Pradesh govt to enact law on education medium
The state government has decided to make English the medium of instruction for classes 1 to 6 in all schools, replacing the native language Telugu, beginning from 2020-21 academic year, with Telugu or Urdu being a compulsory subject.
India vulnerable to oil price and capital inflow shocks: YV Reddy
According to the former Reserve Bank of India governor, there are three eco...
Telugu-English divide pits others against Jagan Mohan Reddy
In a step to make students employable and thereby eradicate poverty, Andhra Prade...
Avoid metals in long term, go for India focused pharma cos: Sudip Bandyopadhyay
The uncertainties on the back of the tariff war have not ended, says Inditrade Cap group chairman.
Dr Reddy's forays into nutrition segment; launches diabetic-friendly drink
It is a first-of-its-kind under Dr Reddy's nutrition portfolio and clinically proven to help manage blood glucose levels among Indian patients. The brand 'Celevida' is derived from two words 'Celebration' and 'Vida', which means 'Celebrate Life'. It is available in two flavours Kesar Elachi and Chocolate, which are taste tested with over 300 diabetics and prediabetics, it said.
Share market update: Nifty Pharma index dips; Dr. Reddy's Lab down 2%
The Nifty Pharma index was trading 0.37 per cent down at 8243.
Many states, union territories reported 'nil' data on farmer suicides: Home Ministry
Minister of State for Home Affairs G Kishan Reddy said this in response to a question by Congress leader Rahul Gandhi seeking to know if the farmer suicide data for the past four years was available.
Parliament passes bill for stringent punishment to those carrying, manufacturing illegal weapons
Moving the legislation in the Upper House, Union Minister of State for Home G Kishan Reddy said effective control over arms and ammunition is very important for safety and security in the country. He said the bill seeks to bring in stringent punishment for people involved in illegal manufacturing of arms while ensuring easier provisions for people with licensed arms.
Govt duty-bound to set up trust within 3 months to construct Ram temple in Ayodhya
The Centre is duty-bound to set up a new trust for the development of Ayodhya and construction of a Ram temple within three months as per the directive of the Supreme Court, Union Minister of State for Home G Kishan Reddy said.
Andhra CM has a word of praise for Hyderabad ‘encounter’
Andhra Pradesh chief minister YS Jaganmohan Reddy has emerged as the first head of a legislative body to support the alleged encounter, wherein the Telangana police had on Friday gunned down all the four suspects in the rape and murder of a 26-year-old veterinarian.
Health-tech startup Arvi launches at-home medical alert system for senior citizens
Arvi installs a smart medical alert system with ‘push buttons’ at all critical locations of the house.
Buy Dr. Reddy's Laboratories, price target Rs 3,060: Sagar Doshi
The analyst suggested a stoploss at Rs 2920.
Parliamentary panel calls for restoration of financial credit instruments with proper safeguards
Voicing concern over discontinuation of LoU/ LoC that is impinging trade and commerce in labour intensive and MSME Sectors, the Panel expressed concern on the absence of any prescribed norms for resolutions of NPAs due to quashing of RBI Circular dated February 12, 2018 by Supreme Court: Recommends a realistic framework for resolution of stressed assets.
182 incidents of flying drones observed along border areas, government tells Rajya Sabha
"As per information received, 182 incidents of flying of drones have been observed on the borders," Union Minister G Kishan Reddy said in RS on Wednesday in response to a written question. He added, the IAF is the main airspace control agency & continues to train all security agencies and all state & union territory police forces on anti-drone measures.
SBI Cap Securities upgrades Dr Reddy's Labs to buy, target price Rs 3,200
Buy Dr. Reddy's Laboratories Ltd. at a price target of Rs 3200.0 .
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service